IL301563A

IL301563A - Recombinant adeno-associated viruses for cns or muscle delivery

Recombinant adeno-associated viruses for cns or muscle delivery

Info

Publication number: IL301563A
Authority: IL; Israel
Prior art keywords: capsid; aav; seq; aav9; raav
Prior art date: 2020-10-07

Application number

IL301563A

Other languages

English (en)

Hebrew (he)

Original Assignee

Regenxbio Inc

Priority date

2020-10-07

Filing date

2021-10-07

Publication date

2023-05-01

2021-10-07 Application filed by Regenxbio Inc filed Critical Regenxbio Inc

2021-10-07 Priority claimed from PCT/US2021/054058 external-priority patent/WO2022076750A2/en

2023-05-01 Publication of IL301563A publication Critical patent/IL301563A/en

Links

241000702421 Dependoparvovirus Species 0.000 title claims description 68
210000003169 central nervous system Anatomy 0.000 title description 51
238000007918 intramuscular administration Methods 0.000 title description 4
210000000234 capsid Anatomy 0.000 claims description 498
108090000765 processed proteins & peptides Proteins 0.000 claims description 188
210000004027 cell Anatomy 0.000 claims description 156
108090000565 Capsid Proteins Proteins 0.000 claims description 146
102100023321 Ceruloplasmin Human genes 0.000 claims description 146
238000003780 insertion Methods 0.000 claims description 138
230000037431 insertion Effects 0.000 claims description 138
238000010361 transduction Methods 0.000 claims description 129
230000026683 transduction Effects 0.000 claims description 128
238000006467 substitution reaction Methods 0.000 claims description 124
108700019146 Transgenes Proteins 0.000 claims description 108
239000013598 vector Substances 0.000 claims description 103
210000001519 tissue Anatomy 0.000 claims description 99
125000003275 alpha amino acid group Chemical group 0.000 claims description 96
239000013608 rAAV vector Substances 0.000 claims description 84
238000000034 method Methods 0.000 claims description 68
108090000623 proteins and genes Proteins 0.000 claims description 62
210000004185 liver Anatomy 0.000 claims description 60
239000008194 pharmaceutical composition Substances 0.000 claims description 47
210000003594 spinal ganglia Anatomy 0.000 claims description 45
230000008685 targeting Effects 0.000 claims description 45
230000001225 therapeutic effect Effects 0.000 claims description 45
102000004169 proteins and genes Human genes 0.000 claims description 40
230000010354 integration Effects 0.000 claims description 33
230000014509 gene expression Effects 0.000 claims description 32
210000002027 skeletal muscle Anatomy 0.000 claims description 27
241001634120 Adeno-associated virus - 5 Species 0.000 claims description 23
238000004806 packaging method and process Methods 0.000 claims description 23
239000013607 AAV vector Substances 0.000 claims description 22
210000004165 myocardium Anatomy 0.000 claims description 22
210000003205 muscle Anatomy 0.000 claims description 21
241000580270 Adeno-associated virus - 4 Species 0.000 claims description 20
150000007523 nucleic acids Chemical class 0.000 claims description 19
241001164823 Adeno-associated virus - 7 Species 0.000 claims description 16
230000003247 decreasing effect Effects 0.000 claims description 14
230000001965 increasing effect Effects 0.000 claims description 14
208000015114 central nervous system disease Diseases 0.000 claims description 13
108020004707 nucleic acids Proteins 0.000 claims description 13
102000039446 nucleic acids Human genes 0.000 claims description 13
208000029578 Muscle disease Diseases 0.000 claims description 12
239000003937 drug carrier Substances 0.000 claims description 8
230000001105 regulatory effect Effects 0.000 claims description 8
210000004413 cardiac myocyte Anatomy 0.000 claims description 7
210000002363 skeletal muscle cell Anatomy 0.000 claims description 7
210000005229 liver cell Anatomy 0.000 claims description 6
125000003729 nucleotide group Chemical group 0.000 claims description 6
210000000578 peripheral nerve Anatomy 0.000 claims description 6
208000019622 heart disease Diseases 0.000 claims description 5
239000002773 nucleotide Substances 0.000 claims description 5
208000021642 Muscular disease Diseases 0.000 claims description 2
230000004071 biological effect Effects 0.000 claims description 2
241001164825 Adeno-associated virus - 8 Species 0.000 claims 4
235000001014 amino acid Nutrition 0.000 description 101
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 80
230000008499 blood brain barrier function Effects 0.000 description 52
210000001218 blood-brain barrier Anatomy 0.000 description 52
239000003795 chemical substances by application Substances 0.000 description 52
201000010099 disease Diseases 0.000 description 50
150000001413 amino acids Chemical group 0.000 description 49
229940024606 amino acid Drugs 0.000 description 46
241001465754 Metazoa Species 0.000 description 44
210000004556 brain Anatomy 0.000 description 41
238000001990 intravenous administration Methods 0.000 description 41
241000699670 Mus sp. Species 0.000 description 38
235000018102 proteins Nutrition 0.000 description 35
238000012384 transportation and delivery Methods 0.000 description 34
239000000203 mixture Substances 0.000 description 33
238000011282 treatment Methods 0.000 description 31
208000002267 Anti-neutrophil cytoplasmic antibody-associated vasculitis Diseases 0.000 description 30
208000035475 disorder Diseases 0.000 description 30
239000002245 particle Substances 0.000 description 30
241000282567 Macaca fascicularis Species 0.000 description 29
108020004414 DNA Proteins 0.000 description 28
230000000069 prophylactic effect Effects 0.000 description 28
239000005090 green fluorescent protein Substances 0.000 description 26
230000003612 virological effect Effects 0.000 description 26
108010043121 Green Fluorescent Proteins Proteins 0.000 description 24
102000004144 Green Fluorescent Proteins Human genes 0.000 description 24
238000004458 analytical method Methods 0.000 description 24
102000004196 processed proteins & peptides Human genes 0.000 description 23
230000004048 modification Effects 0.000 description 22
238000012986 modification Methods 0.000 description 22
230000002829 reductive effect Effects 0.000 description 22
239000003814 drug Substances 0.000 description 21
241001655883 Adeno-associated virus - 1 Species 0.000 description 19
210000003734 kidney Anatomy 0.000 description 19
241000972680 Adeno-associated virus - 6 Species 0.000 description 18
238000010586 diagram Methods 0.000 description 18
210000002216 heart Anatomy 0.000 description 18
239000000523 sample Substances 0.000 description 17
125000000539 amino acid group Chemical group 0.000 description 16
238000009826 distribution Methods 0.000 description 16
238000007481 next generation sequencing Methods 0.000 description 16
229940124597 therapeutic agent Drugs 0.000 description 16
210000004369 blood Anatomy 0.000 description 15
239000008280 blood Substances 0.000 description 15
230000000694 effects Effects 0.000 description 15
241000699666 Mus <mouse, genus> Species 0.000 description 14
210000001320 hippocampus Anatomy 0.000 description 14
238000004519 manufacturing process Methods 0.000 description 14
238000000185 intracerebroventricular administration Methods 0.000 description 13
201000006938 muscular dystrophy Diseases 0.000 description 13
230000010415 tropism Effects 0.000 description 13
238000011529 RT qPCR Methods 0.000 description 12
235000004279 alanine Nutrition 0.000 description 12
238000004113 cell culture Methods 0.000 description 12
230000035772 mutation Effects 0.000 description 12
230000002093 peripheral effect Effects 0.000 description 12
241000700605 Viruses Species 0.000 description 11
235000009582 asparagine Nutrition 0.000 description 11
238000003556 assay Methods 0.000 description 11
238000001415 gene therapy Methods 0.000 description 11
238000000338 in vitro Methods 0.000 description 11
108091032973 (ribonucleotides)n+m Proteins 0.000 description 10
208000018737 Parkinson disease Diseases 0.000 description 10
239000002253 acid Substances 0.000 description 10
150000001295 alanines Chemical class 0.000 description 10
150000001508 asparagines Chemical class 0.000 description 10
210000005153 frontal cortex Anatomy 0.000 description 10
239000000047 product Substances 0.000 description 10
241000202702 Adeno-associated virus - 3 Species 0.000 description 9
230000003472 neutralizing effect Effects 0.000 description 9
230000002463 transducing effect Effects 0.000 description 9
241000701161 unidentified adenovirus Species 0.000 description 9
101150044789 Cap gene Proteins 0.000 description 8
238000010171 animal model Methods 0.000 description 8
210000001638 cerebellum Anatomy 0.000 description 8
230000008859 change Effects 0.000 description 8
238000001727 in vivo Methods 0.000 description 8
238000002347 injection Methods 0.000 description 8
239000007924 injection Substances 0.000 description 8
208000024891 symptom Diseases 0.000 description 8
238000012360 testing method Methods 0.000 description 8
230000005100 tissue tropism Effects 0.000 description 8
231100000419 toxicity Toxicity 0.000 description 8
230000001988 toxicity Effects 0.000 description 8
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
238000013270 controlled release Methods 0.000 description 7
230000014759 maintenance of location Effects 0.000 description 7
239000011159 matrix material Substances 0.000 description 7
210000001259 mesencephalon Anatomy 0.000 description 7
230000001537 neural effect Effects 0.000 description 7
239000013612 plasmid Substances 0.000 description 7
238000001890 transfection Methods 0.000 description 7
241000958487 Adeno-associated virus 3B Species 0.000 description 6
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
108060001084 Luciferase Proteins 0.000 description 6
238000011887 Necropsy Methods 0.000 description 6
241000288906 Primates Species 0.000 description 6
241000700159 Rattus Species 0.000 description 6
206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 6
230000008901 benefit Effects 0.000 description 6
238000010276 construction Methods 0.000 description 6
238000009472 formulation Methods 0.000 description 6
238000001802 infusion Methods 0.000 description 6
210000004072 lung Anatomy 0.000 description 6
210000003497 sciatic nerve Anatomy 0.000 description 6
239000011780 sodium chloride Substances 0.000 description 6
239000006228 supernatant Substances 0.000 description 6
210000000115 thoracic cavity Anatomy 0.000 description 6
241000282693 Cercopithecidae Species 0.000 description 5
108091092584 GDNA Proteins 0.000 description 5
241000282412 Homo Species 0.000 description 5
206010028980 Neoplasm Diseases 0.000 description 5
101710163270 Nuclease Proteins 0.000 description 5
108091028043 Nucleic acid sequence Proteins 0.000 description 5
230000008827 biological function Effects 0.000 description 5
230000037396 body weight Effects 0.000 description 5
210000001175 cerebrospinal fluid Anatomy 0.000 description 5
230000007812 deficiency Effects 0.000 description 5
238000009792 diffusion process Methods 0.000 description 5
238000001476 gene delivery Methods 0.000 description 5
230000002068 genetic effect Effects 0.000 description 5
239000007788 liquid Substances 0.000 description 5
210000000056 organ Anatomy 0.000 description 5
230000009467 reduction Effects 0.000 description 5
230000010076 replication Effects 0.000 description 5
239000000243 solution Substances 0.000 description 5
208000002320 spinal muscular atrophy Diseases 0.000 description 5
238000013518 transcription Methods 0.000 description 5
230000035897 transcription Effects 0.000 description 5
210000003462 vein Anatomy 0.000 description 5
206010011906 Death Diseases 0.000 description 4
102100035426 DnaJ homolog subfamily B member 7 Human genes 0.000 description 4
101100285903 Drosophila melanogaster Hsc70-2 gene Proteins 0.000 description 4
101100178718 Drosophila melanogaster Hsc70-4 gene Proteins 0.000 description 4
101100178723 Drosophila melanogaster Hsc70-5 gene Proteins 0.000 description 4
208000031886 HIV Infections Diseases 0.000 description 4
101000804114 Homo sapiens DnaJ homolog subfamily B member 7 Proteins 0.000 description 4
101150090950 Hsc70-1 gene Proteins 0.000 description 4
239000005089 Luciferase Substances 0.000 description 4
208000002537 Neuronal Ceroid-Lipofuscinoses Diseases 0.000 description 4
241000283973 Oryctolagus cuniculus Species 0.000 description 4
LGCMKPRGGJRYGM-UHFFFAOYSA-N Osalmid Chemical compound C1=CC(O)=CC=C1NC(=O)C1=CC=CC=C1O LGCMKPRGGJRYGM-UHFFFAOYSA-N 0.000 description 4
101100150366 Schizosaccharomyces pombe (strain 972 / ATCC 24843) sks2 gene Proteins 0.000 description 4
239000013543 active substance Substances 0.000 description 4
238000012217 deletion Methods 0.000 description 4
230000037430 deletion Effects 0.000 description 4
238000013461 design Methods 0.000 description 4
229940079593 drug Drugs 0.000 description 4
239000004615 ingredient Substances 0.000 description 4
210000000663 muscle cell Anatomy 0.000 description 4
210000001672 ovary Anatomy 0.000 description 4
229920000642 polymer Polymers 0.000 description 4
238000012552 review Methods 0.000 description 4
239000000725 suspension Substances 0.000 description 4
238000013268 sustained release Methods 0.000 description 4
239000012730 sustained-release form Substances 0.000 description 4
238000012546 transfer Methods 0.000 description 4
JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 4
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 3
241000702423 Adeno-associated virus - 2 Species 0.000 description 3
241000649045 Adeno-associated virus 10 Species 0.000 description 3
241000649046 Adeno-associated virus 11 Species 0.000 description 3
241000649047 Adeno-associated virus 12 Species 0.000 description 3
241000300529 Adeno-associated virus 13 Species 0.000 description 3
102100035028 Alpha-L-iduronidase Human genes 0.000 description 3
239000004475 Arginine Substances 0.000 description 3
241000283690 Bos taurus Species 0.000 description 3
241000282472 Canis lupus familiaris Species 0.000 description 3
102100029140 Cyclic nucleotide-gated cation channel beta-3 Human genes 0.000 description 3
241000701022 Cytomegalovirus Species 0.000 description 3
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
102100024785 Fibroblast growth factor 2 Human genes 0.000 description 3
108090000379 Fibroblast growth factor 2 Proteins 0.000 description 3
208000017462 Galactosialidosis Diseases 0.000 description 3
241000287828 Gallus gallus Species 0.000 description 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
101000771083 Homo sapiens Cyclic nucleotide-gated cation channel beta-3 Proteins 0.000 description 3
108010000521 Human Growth Hormone Proteins 0.000 description 3
102000002265 Human Growth Hormone Human genes 0.000 description 3
239000000854 Human Growth Hormone Substances 0.000 description 3
102100029199 Iduronate 2-sulfatase Human genes 0.000 description 3
101710096421 Iduronate 2-sulfatase Proteins 0.000 description 3
241000124008 Mammalia Species 0.000 description 3
102100021584 Neurturin Human genes 0.000 description 3
108010015406 Neurturin Proteins 0.000 description 3
102100026459 POU domain, class 3, transcription factor 2 Human genes 0.000 description 3
101710133394 POU domain, class 3, transcription factor 2 Proteins 0.000 description 3
108091081024 Start codon Proteins 0.000 description 3
241000282887 Suidae Species 0.000 description 3
239000003708 ampul Substances 0.000 description 3
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
206010003246 arthritis Diseases 0.000 description 3
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
210000004958 brain cell Anatomy 0.000 description 3
230000000747 cardiac effect Effects 0.000 description 3
230000001413 cellular effect Effects 0.000 description 3
208000013896 centronuclear myopathy X-linked Diseases 0.000 description 3
239000002299 complementary DNA Substances 0.000 description 3
125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 3
230000002950 deficient Effects 0.000 description 3
239000002552 dosage form Substances 0.000 description 3
230000009977 dual effect Effects 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
230000001747 exhibiting effect Effects 0.000 description 3
230000002349 favourable effect Effects 0.000 description 3
230000006870 function Effects 0.000 description 3
230000028993 immune response Effects 0.000 description 3
238000000099 in vitro assay Methods 0.000 description 3
238000010348 incorporation Methods 0.000 description 3
238000007913 intrathecal administration Methods 0.000 description 3
238000009593 lumbar puncture Methods 0.000 description 3
239000008176 lyophilized powder Substances 0.000 description 3
239000000463 material Substances 0.000 description 3
210000004379 membrane Anatomy 0.000 description 3
239000012528 membrane Substances 0.000 description 3
238000010232 migration assay Methods 0.000 description 3
238000009126 molecular therapy Methods 0.000 description 3
210000001577 neostriatum Anatomy 0.000 description 3
201000007607 neuronal ceroid lipofuscinosis 3 Diseases 0.000 description 3
230000002276 neurotropic effect Effects 0.000 description 3
210000001328 optic nerve Anatomy 0.000 description 3
210000001428 peripheral nervous system Anatomy 0.000 description 3
239000000546 pharmaceutical excipient Substances 0.000 description 3
230000002265 prevention Effects 0.000 description 3
101150066583 rep gene Proteins 0.000 description 3
210000002966 serum Anatomy 0.000 description 3
210000000278 spinal cord Anatomy 0.000 description 3
208000011580 syndromic disease Diseases 0.000 description 3
238000007910 systemic administration Methods 0.000 description 3
230000009885 systemic effect Effects 0.000 description 3
238000002560 therapeutic procedure Methods 0.000 description 3
230000032258 transport Effects 0.000 description 3
239000003981 vehicle Substances 0.000 description 3
QVQOGNOOAMQKCE-ZTYVOHGWSA-N (2s)-n-[(2s)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[(10r,13s,16s,19s,22s)-13-(2-amino-2-oxoethyl)-16-(3-amino-3-oxopropyl)-19-benzyl-22-[(4-methoxyphenyl)methyl]-12,15,18,21,24-pentaoxo-7,8-dithia-11,14,17,20,23-pen Chemical compound C1=CC(OC)=CC=C1C[C@H]1C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)CSSC2(CCCCC2)CC(=O)N1 QVQOGNOOAMQKCE-ZTYVOHGWSA-N 0.000 description 2
108700005160 1-(1-mercaptocyclohexaneacetic acid)-2-(O- methyl-L-tyrosine)-8-L-arginine- vasopressin Proteins 0.000 description 2
VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
208000031277 Amaurotic familial idiocy Diseases 0.000 description 2
101710081722 Antitrypsin Proteins 0.000 description 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
102000009039 Axonemal Dyneins Human genes 0.000 description 2
108010049197 Axonemal Dyneins Proteins 0.000 description 2
102100022440 Battenin Human genes 0.000 description 2
201000004569 Blindness Diseases 0.000 description 2
238000011740 C57BL/6 mouse Methods 0.000 description 2
108090000489 Carboxy-Lyases Proteins 0.000 description 2
102000004031 Carboxy-Lyases Human genes 0.000 description 2
102100034480 Ceroid-lipofuscinosis neuronal protein 6 Human genes 0.000 description 2
102100022641 Coagulation factor IX Human genes 0.000 description 2
206010010356 Congenital anomaly Diseases 0.000 description 2
102100029142 Cyclic nucleotide-gated cation channel alpha-3 Human genes 0.000 description 2
102000053602 DNA Human genes 0.000 description 2
108010008532 Deoxyribonuclease I Proteins 0.000 description 2
102000007260 Deoxyribonuclease I Human genes 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
241000283086 Equidae Species 0.000 description 2
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
XZWYTXMRWQJBGX-VXBMVYAYSA-N FLAG peptide Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)CC1=CC=C(O)C=C1 XZWYTXMRWQJBGX-VXBMVYAYSA-N 0.000 description 2
241000282326 Felis catus Species 0.000 description 2
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
208000024412 Friedreich ataxia Diseases 0.000 description 2
208000033136 Gamma-sarcoglycan-related limb-girdle muscular dystrophy R5 Diseases 0.000 description 2
108010010803 Gelatin Proteins 0.000 description 2
108010017544 Glucosylceramidase Proteins 0.000 description 2
102000004547 Glucosylceramidase Human genes 0.000 description 2
108091022930 Glutamate decarboxylase Proteins 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
206010019280 Heart failures Diseases 0.000 description 2
241000238631 Hexapoda Species 0.000 description 2
101001019502 Homo sapiens Alpha-L-iduronidase Proteins 0.000 description 2
101000710215 Homo sapiens Ceroid-lipofuscinosis neuronal protein 6 Proteins 0.000 description 2
101000771071 Homo sapiens Cyclic nucleotide-gated cation channel alpha-3 Proteins 0.000 description 2
101000997662 Homo sapiens Lysosomal acid glucosylceramidase Proteins 0.000 description 2
206010061598 Immunodeficiency Diseases 0.000 description 2
208000029462 Immunodeficiency disease Diseases 0.000 description 2
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
201000003533 Leber congenital amaurosis Diseases 0.000 description 2
102100033342 Lysosomal acid glucosylceramidase Human genes 0.000 description 2
102100033448 Lysosomal alpha-glucosidase Human genes 0.000 description 2
241000702623 Minute virus of mice Species 0.000 description 2
108091034117 Oligonucleotide Proteins 0.000 description 2
239000002202 Polyethylene glycol Substances 0.000 description 2
108700008625 Reporter Genes Proteins 0.000 description 2
208000007014 Retinitis pigmentosa Diseases 0.000 description 2
241000714474 Rous sarcoma virus Species 0.000 description 2
108091027967 Small hairpin RNA Proteins 0.000 description 2
208000032978 Structural Congenital Myopathies Diseases 0.000 description 2
102000005262 Sulfatase Human genes 0.000 description 2
102000002248 Thyroxine-Binding Globulin Human genes 0.000 description 2
108010000259 Thyroxine-Binding Globulin Proteins 0.000 description 2
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 2
102100029152 UDP-glucuronosyltransferase 1A1 Human genes 0.000 description 2
101710205316 UDP-glucuronosyltransferase 1A1 Proteins 0.000 description 2
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
239000002671 adjuvant Substances 0.000 description 2
206010001902 amaurosis Diseases 0.000 description 2
230000001475 anti-trypsic effect Effects 0.000 description 2
239000000427 antigen Substances 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
201000009562 autosomal recessive limb-girdle muscular dystrophy type 2C Diseases 0.000 description 2
102000007478 beta-N-Acetylhexosaminidases Human genes 0.000 description 2
108010085377 beta-N-Acetylhexosaminidases Proteins 0.000 description 2
108010046910 brain-derived growth factor Proteins 0.000 description 2
210000004899 c-terminal region Anatomy 0.000 description 2
239000002775 capsule Substances 0.000 description 2
239000000969 carrier Substances 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
239000012141 concentrate Substances 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
238000001514 detection method Methods 0.000 description 2
238000011161 development Methods 0.000 description 2
VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
229940088598 enzyme Drugs 0.000 description 2
210000001508 eye Anatomy 0.000 description 2
238000002073 fluorescence micrograph Methods 0.000 description 2
230000004927 fusion Effects 0.000 description 2
239000000499 gel Substances 0.000 description 2
239000008273 gelatin Substances 0.000 description 2
229920000159 gelatin Polymers 0.000 description 2
235000019322 gelatine Nutrition 0.000 description 2
235000011852 gelatine desserts Nutrition 0.000 description 2
238000010362 genome editing Methods 0.000 description 2
230000002518 glial effect Effects 0.000 description 2
239000008103 glucose Substances 0.000 description 2
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
150000004676 glycans Chemical class 0.000 description 2
239000003102 growth factor Substances 0.000 description 2
229920000669 heparin Polymers 0.000 description 2
208000014188 hereditary optic neuropathy Diseases 0.000 description 2
230000007813 immunodeficiency Effects 0.000 description 2
238000011532 immunohistochemical staining Methods 0.000 description 2
238000001114 immunoprecipitation Methods 0.000 description 2
230000001976 improved effect Effects 0.000 description 2
201000008319 inclusion body myositis Diseases 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
230000003993 interaction Effects 0.000 description 2
238000007912 intraperitoneal administration Methods 0.000 description 2
208000017476 juvenile neuronal ceroid lipofuscinosis Diseases 0.000 description 2
208000025014 late infantile neuronal ceroid lipofuscinosis Diseases 0.000 description 2
239000002502 liposome Substances 0.000 description 2
210000005244 lower chamber Anatomy 0.000 description 2
238000007726 management method Methods 0.000 description 2
238000013507 mapping Methods 0.000 description 2
230000001404 mediated effect Effects 0.000 description 2
108091070501 miRNA Proteins 0.000 description 2
239000002679 microRNA Substances 0.000 description 2
238000010172 mouse model Methods 0.000 description 2
208000022018 mucopolysaccharidosis type 2 Diseases 0.000 description 2
208000025919 mucopolysaccharidosis type 7 Diseases 0.000 description 2
238000002703 mutagenesis Methods 0.000 description 2
231100000350 mutagenesis Toxicity 0.000 description 2
210000003098 myoblast Anatomy 0.000 description 2
201000007633 neuronal ceroid lipofuscinosis 2 Diseases 0.000 description 2
201000001119 neuropathy Diseases 0.000 description 2
230000007823 neuropathy Effects 0.000 description 2
238000006386 neutralization reaction Methods 0.000 description 2
229910052757 nitrogen Inorganic materials 0.000 description 2
230000003287 optical effect Effects 0.000 description 2
210000000496 pancreas Anatomy 0.000 description 2
210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 2
208000033808 peripheral neuropathy Diseases 0.000 description 2
239000000825 pharmaceutical preparation Substances 0.000 description 2
229920001983 poloxamer Polymers 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
239000013641 positive control Substances 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
208000022587 qualitative or quantitative defects of dystrophin Diseases 0.000 description 2
208000022577 qualitative or quantitative defects of gamma-sarcoglycan Diseases 0.000 description 2
239000013646 rAAV2 vector Substances 0.000 description 2
238000003753 real-time PCR Methods 0.000 description 2
239000011347 resin Substances 0.000 description 2
229920005989 resin Polymers 0.000 description 2
230000004044 response Effects 0.000 description 2
210000000844 retinal pigment epithelial cell Anatomy 0.000 description 2
201000007714 retinoschisis Diseases 0.000 description 2
238000012216 screening Methods 0.000 description 2
239000004055 small Interfering RNA Substances 0.000 description 2
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
239000000126 substance Substances 0.000 description 2
108060007951 sulfatase Proteins 0.000 description 2
XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 2
231100000331 toxic Toxicity 0.000 description 2
230000002588 toxic effect Effects 0.000 description 2
230000031998 transcytosis Effects 0.000 description 2
239000002753 trypsin inhibitor Substances 0.000 description 2
102000003298 tumor necrosis factor receptor Human genes 0.000 description 2
230000009385 viral infection Effects 0.000 description 2
239000013603 viral vector Substances 0.000 description 2
239000011592 zinc chloride Substances 0.000 description 2
235000005074 zinc chloride Nutrition 0.000 description 2
UPXRTVAIJMUAQR-UHFFFAOYSA-N 4-(9h-fluoren-9-ylmethoxycarbonylamino)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid Chemical compound C1C(C(O)=O)N(C(=O)OC(C)(C)C)CC1NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21 UPXRTVAIJMUAQR-UHFFFAOYSA-N 0.000 description 1
102100022712 Alpha-1-antitrypsin Human genes 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
208000024827 Alzheimer disease Diseases 0.000 description 1
206010002091 Anaesthesia Diseases 0.000 description 1
206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
102100030942 Apolipoprotein A-II Human genes 0.000 description 1
102100038238 Aromatic-L-amino-acid decarboxylase Human genes 0.000 description 1
101710151768 Aromatic-L-amino-acid decarboxylase Proteins 0.000 description 1
102100031491 Arylsulfatase B Human genes 0.000 description 1
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
108010089996 B-domain-deleted factor VIII Proteins 0.000 description 1
102100028215 BTB/POZ domain-containing protein KCTD7 Human genes 0.000 description 1
102100031504 Beta-1,4 N-acetylgalactosaminyltransferase 2 Human genes 0.000 description 1
102100022548 Beta-hexosaminidase subunit alpha Human genes 0.000 description 1
102100032487 Beta-mannosidase Human genes 0.000 description 1
102100024522 Bladder cancer-associated protein Human genes 0.000 description 1
101150110835 Blcap gene Proteins 0.000 description 1
108091033409 CRISPR Proteins 0.000 description 1
238000010354 CRISPR gene editing Methods 0.000 description 1
102100035602 Calsequestrin-2 Human genes 0.000 description 1
208000022526 Canavan disease Diseases 0.000 description 1
101100348617 Candida albicans (strain SC5314 / ATCC MYA-2876) NIK1 gene Proteins 0.000 description 1
102100025953 Cathepsin F Human genes 0.000 description 1
201000003728 Centronuclear myopathy Diseases 0.000 description 1
241001432959 Chernes Species 0.000 description 1
208000033810 Choroidal dystrophy Diseases 0.000 description 1
208000000094 Chronic Pain Diseases 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
208000003322 Coinfection Diseases 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
206010009944 Colon cancer Diseases 0.000 description 1
208000006992 Color Vision Defects Diseases 0.000 description 1
102100039484 Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' Human genes 0.000 description 1
108091035707 Consensus sequence Proteins 0.000 description 1
241000699800 Cricetinae Species 0.000 description 1
201000003883 Cystic fibrosis Diseases 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
241000450599 DNA viruses Species 0.000 description 1
239000004375 Dextrin Substances 0.000 description 1
229920001353 Dextrin Polymers 0.000 description 1
MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
102100031675 DnaJ homolog subfamily C member 5 Human genes 0.000 description 1
206010013801 Duchenne Muscular Dystrophy Diseases 0.000 description 1
102100032248 Dysferlin Human genes 0.000 description 1
102000001039 Dystrophin Human genes 0.000 description 1
108010069091 Dystrophin Proteins 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
238000012286 ELISA Assay Methods 0.000 description 1
108010020195 FLAG peptide Proteins 0.000 description 1
208000024720 Fabry Disease Diseases 0.000 description 1
108010076282 Factor IX Proteins 0.000 description 1
108010054218 Factor VIII Proteins 0.000 description 1
102000001690 Factor VIII Human genes 0.000 description 1
201000008808 Fibrosarcoma Diseases 0.000 description 1
102000003869 Frataxin Human genes 0.000 description 1
108090000217 Frataxin Proteins 0.000 description 1
101150096822 Fuca1 gene Proteins 0.000 description 1
102000024452 GDNF Human genes 0.000 description 1
101000834253 Gallus gallus Actin, cytoplasmic 1 Proteins 0.000 description 1
102000019344 Gamma-sarcoglycan Human genes 0.000 description 1
208000003098 Ganglion Cysts Diseases 0.000 description 1
208000015872 Gaucher disease Diseases 0.000 description 1
108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
108091010837 Glial cell line-derived neurotrophic factor Proteins 0.000 description 1
201000010915 Glioblastoma multiforme Diseases 0.000 description 1
102000053187 Glucuronidase Human genes 0.000 description 1
108010060309 Glucuronidase Proteins 0.000 description 1
102000008214 Glutamate decarboxylase Human genes 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
208000032007 Glycogen storage disease due to acid maltase deficiency Diseases 0.000 description 1
206010053185 Glycogen storage disease type II Diseases 0.000 description 1
102100039214 Guanine nucleotide-binding protein G(t) subunit alpha-2 Human genes 0.000 description 1
101100412102 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) rec2 gene Proteins 0.000 description 1
229920002971 Heparan sulfate Polymers 0.000 description 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
101000823116 Homo sapiens Alpha-1-antitrypsin Proteins 0.000 description 1
101000703500 Homo sapiens Alpha-sarcoglycan Proteins 0.000 description 1
101000793406 Homo sapiens Apolipoprotein A-II Proteins 0.000 description 1
101001007222 Homo sapiens BTB/POZ domain-containing protein KCTD7 Proteins 0.000 description 1
101000901683 Homo sapiens Battenin Proteins 0.000 description 1
101000729812 Homo sapiens Beta-1,4 N-acetylgalactosaminyltransferase 2 Proteins 0.000 description 1
101000947118 Homo sapiens Calsequestrin-2 Proteins 0.000 description 1
101000933218 Homo sapiens Cathepsin F Proteins 0.000 description 1
101000609790 Homo sapiens Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' Proteins 0.000 description 1
101000845893 Homo sapiens DnaJ homolog subfamily C member 5 Proteins 0.000 description 1
101001016184 Homo sapiens Dysferlin Proteins 0.000 description 1
101000888142 Homo sapiens Guanine nucleotide-binding protein G(t) subunit alpha-2 Proteins 0.000 description 1
101000575454 Homo sapiens Major facilitator superfamily domain-containing protein 8 Proteins 0.000 description 1
101000887201 Homo sapiens Polyamine-transporting ATPase 13A2 Proteins 0.000 description 1
101001067140 Homo sapiens Porphobilinogen deaminase Proteins 0.000 description 1
101001027324 Homo sapiens Progranulin Proteins 0.000 description 1
101000710213 Homo sapiens Protein CLN8 Proteins 0.000 description 1
101000600434 Homo sapiens Putative uncharacterized protein encoded by MIR7-3HG Proteins 0.000 description 1
101001078886 Homo sapiens Retinaldehyde-binding protein 1 Proteins 0.000 description 1
101000729271 Homo sapiens Retinoid isomerohydrolase Proteins 0.000 description 1
101000640899 Homo sapiens Solute carrier family 12 member 2 Proteins 0.000 description 1
101001104102 Homo sapiens X-linked retinitis pigmentosa GTPase regulator Proteins 0.000 description 1
108090000144 Human Proteins Proteins 0.000 description 1
102000003839 Human Proteins Human genes 0.000 description 1
208000023105 Huntington disease Diseases 0.000 description 1
108010003272 Hyaluronate lyase Proteins 0.000 description 1
102000009066 Hyaluronoglucosaminidase Human genes 0.000 description 1
208000001021 Hyperlipoproteinemia Type I Diseases 0.000 description 1
206010021143 Hypoxia Diseases 0.000 description 1
108010003381 Iduronidase Proteins 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 1
108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 1
229930010555 Inosine Natural products 0.000 description 1
UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
108091092195 Intron Proteins 0.000 description 1
PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
208000032420 Latent Infection Diseases 0.000 description 1
108010013563 Lipoprotein Lipase Proteins 0.000 description 1
102100022119 Lipoprotein lipase Human genes 0.000 description 1
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
208000015439 Lysosomal storage disease Diseases 0.000 description 1
102000009565 Lysosomal-Associated Membrane Protein 2 Human genes 0.000 description 1
108010009491 Lysosomal-Associated Membrane Protein 2 Proteins 0.000 description 1
101150083522 MECP2 gene Proteins 0.000 description 1
102100025613 Major facilitator superfamily domain-containing protein 8 Human genes 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
102100039124 Methyl-CpG-binding protein 2 Human genes 0.000 description 1
108091007780 MiR-122 Proteins 0.000 description 1
208000002678 Mucopolysaccharidoses Diseases 0.000 description 1
206010028095 Mucopolysaccharidosis IV Diseases 0.000 description 1
206010056893 Mucopolysaccharidosis VII Diseases 0.000 description 1
208000025915 Mucopolysaccharidosis type 6 Diseases 0.000 description 1
108010027520 N-Acetylgalactosamine-4-Sulfatase Proteins 0.000 description 1
GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
108010006140 N-sulfoglucosamine sulfohydrolase Proteins 0.000 description 1
102100027661 N-sulphoglucosamine sulphohydrolase Human genes 0.000 description 1
108010025020 Nerve Growth Factor Proteins 0.000 description 1
206010029350 Neurotoxicity Diseases 0.000 description 1
108091092724 Noncoding DNA Proteins 0.000 description 1
108091005461 Nucleic proteins Proteins 0.000 description 1
240000007594 Oryza sativa Species 0.000 description 1
235000007164 Oryza sativa Nutrition 0.000 description 1
101100493740 Oryza sativa subsp. japonica BC10 gene Proteins 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
208000002193 Pain Diseases 0.000 description 1
101710112083 Para-Rep C1 Proteins 0.000 description 1
241000701945 Parvoviridae Species 0.000 description 1
235000019483 Peanut oil Nutrition 0.000 description 1
102100039917 Polyamine-transporting ATPase 13A2 Human genes 0.000 description 1
102100034391 Porphobilinogen deaminase Human genes 0.000 description 1
241000097929 Porphyria Species 0.000 description 1
208000010642 Porphyrias Diseases 0.000 description 1
102100037632 Progranulin Human genes 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
102100034479 Protein CLN8 Human genes 0.000 description 1
241000125945 Protoparvovirus Species 0.000 description 1
102100037401 Putative uncharacterized protein encoded by MIR7-3HG Human genes 0.000 description 1
102100022881 Rab proteins geranylgeranyltransferase component A 1 Human genes 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
102000018120 Recombinases Human genes 0.000 description 1
108010091086 Recombinases Proteins 0.000 description 1
102100028001 Retinaldehyde-binding protein 1 Human genes 0.000 description 1
102100031176 Retinoid isomerohydrolase Human genes 0.000 description 1
208000006289 Rett Syndrome Diseases 0.000 description 1
101100007329 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) COS1 gene Proteins 0.000 description 1
101100221606 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) COS7 gene Proteins 0.000 description 1
208000021811 Sandhoff disease Diseases 0.000 description 1
108010083379 Sarcoglycans Proteins 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
102000007562 Serum Albumin Human genes 0.000 description 1
108010071390 Serum Albumin Proteins 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
201000001828 Sly syndrome Diseases 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
102000000019 Sterol Esterase Human genes 0.000 description 1
108010055297 Sterol Esterase Proteins 0.000 description 1
208000005718 Stomach Neoplasms Diseases 0.000 description 1
101710172711 Structural protein Proteins 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
108010021188 Superoxide Dismutase-1 Proteins 0.000 description 1
102100038836 Superoxide dismutase [Cu-Zn] Human genes 0.000 description 1
208000005400 Synovial Cyst Diseases 0.000 description 1
-1 TWEENTM Substances 0.000 description 1
208000022292 Tay-Sachs disease Diseases 0.000 description 1
ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
206010044221 Toxic encephalopathy Diseases 0.000 description 1
101710119887 Trans-acting factor B Proteins 0.000 description 1
102100026143 Transferrin receptor protein 2 Human genes 0.000 description 1
101710145355 Transferrin receptor protein 2 Proteins 0.000 description 1
208000030886 Traumatic Brain injury Diseases 0.000 description 1
BGDKAVGWHJFAGW-UHFFFAOYSA-N Tropicamide Chemical compound C=1C=CC=CC=1C(CO)C(=O)N(CC)CC1=CC=NC=C1 BGDKAVGWHJFAGW-UHFFFAOYSA-N 0.000 description 1
208000007930 Type C Niemann-Pick Disease Diseases 0.000 description 1
108091000117 Tyrosine 3-Monooxygenase Proteins 0.000 description 1
102000048218 Tyrosine 3-monooxygenases Human genes 0.000 description 1
208000026589 Wolman disease Diseases 0.000 description 1
208000025033 X-linked centronuclear myopathy Diseases 0.000 description 1
201000001408 X-linked juvenile retinoschisis 1 Diseases 0.000 description 1
102100040092 X-linked retinitis pigmentosa GTPase regulator Human genes 0.000 description 1
208000017441 X-linked retinoschisis Diseases 0.000 description 1
208000005946 Xerostomia Diseases 0.000 description 1
239000002250 absorbent Substances 0.000 description 1
230000002745 absorbent Effects 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
201000000761 achromatopsia Diseases 0.000 description 1
230000002411 adverse Effects 0.000 description 1
125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 1
102000005840 alpha-Galactosidase Human genes 0.000 description 1
108010030291 alpha-Galactosidase Proteins 0.000 description 1
108010028144 alpha-Glucosidases Proteins 0.000 description 1
108010061314 alpha-L-Fucosidase Proteins 0.000 description 1
102000012086 alpha-L-Fucosidase Human genes 0.000 description 1
108010012864 alpha-Mannosidase Proteins 0.000 description 1
102000019199 alpha-Mannosidase Human genes 0.000 description 1
201000008333 alpha-mannosidosis Diseases 0.000 description 1
VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
210000004727 amygdala Anatomy 0.000 description 1
230000037005 anaesthesia Effects 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
235000006708 antioxidants Nutrition 0.000 description 1
238000013459 approach Methods 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
229960001230 asparagine Drugs 0.000 description 1
206010003882 axonal neuropathy Diseases 0.000 description 1
230000007845 axonopathy Effects 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
239000011324 bead Substances 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
MTDHILKWIRSIHB-QZABAPFNSA-N beta-D-glucosamine 6-sulfate Chemical compound N[C@H]1[C@H](O)O[C@H](COS(O)(=O)=O)[C@@H](O)[C@@H]1O MTDHILKWIRSIHB-QZABAPFNSA-N 0.000 description 1
102000005936 beta-Galactosidase Human genes 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
108010055059 beta-Mannosidase Proteins 0.000 description 1
SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
201000006486 beta-mannosidosis Diseases 0.000 description 1
230000002146 bilateral effect Effects 0.000 description 1
239000012620 biological material Substances 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
210000001185 bone marrow Anatomy 0.000 description 1
108010006025 bovine growth hormone Proteins 0.000 description 1
210000005013 brain tissue Anatomy 0.000 description 1
210000000621 bronchi Anatomy 0.000 description 1
239000000872 buffer Substances 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
210000000692 cap cell Anatomy 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
210000004534 cecum Anatomy 0.000 description 1
238000000423 cell based assay Methods 0.000 description 1
108091092356 cellular DNA Proteins 0.000 description 1
230000004700 cellular uptake Effects 0.000 description 1
210000004720 cerebrum Anatomy 0.000 description 1
208000031406 ceroid lipofuscinosis, neuronal, 4 (Kufs type) Diseases 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
235000012000 cholesterol Nutrition 0.000 description 1
208000003571 choroideremia Diseases 0.000 description 1
230000007012 clinical effect Effects 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
210000001072 colon Anatomy 0.000 description 1
208000029742 colonic neoplasm Diseases 0.000 description 1
201000007254 color blindness Diseases 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
108091036078 conserved sequence Proteins 0.000 description 1
239000000599 controlled substance Substances 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
210000003792 cranial nerve Anatomy 0.000 description 1
239000012228 culture supernatant Substances 0.000 description 1
230000001086 cytosolic effect Effects 0.000 description 1
230000006378 damage Effects 0.000 description 1
238000007405 data analysis Methods 0.000 description 1
230000034994 death Effects 0.000 description 1
230000002939 deleterious effect Effects 0.000 description 1
235000019425 dextrin Nutrition 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
208000019409 dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome Diseases 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
230000003292 diminished effect Effects 0.000 description 1
150000002016 disaccharides Chemical class 0.000 description 1
208000037771 disease arising from reactivation of latent virus Diseases 0.000 description 1
229960003638 dopamine Drugs 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
229940126534 drug product Drugs 0.000 description 1
206010013781 dry mouth Diseases 0.000 description 1
210000001198 duodenum Anatomy 0.000 description 1
102000013035 dynein heavy chain Human genes 0.000 description 1
108060002430 dynein heavy chain Proteins 0.000 description 1
230000002526 effect on cardiovascular system Effects 0.000 description 1
238000004520 electroporation Methods 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
210000002889 endothelial cell Anatomy 0.000 description 1
230000003511 endothelial effect Effects 0.000 description 1
238000006911 enzymatic reaction Methods 0.000 description 1
210000002919 epithelial cell Anatomy 0.000 description 1
210000003238 esophagus Anatomy 0.000 description 1
230000005713 exacerbation Effects 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
238000013265 extended release Methods 0.000 description 1
229960004222 factor ix Drugs 0.000 description 1
229960000301 factor viii Drugs 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
239000000796 flavoring agent Substances 0.000 description 1
238000007667 floating Methods 0.000 description 1
235000013312 flour Nutrition 0.000 description 1
238000000684 flow cytometry Methods 0.000 description 1
235000013355 food flavoring agent Nutrition 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
210000003194 forelimb Anatomy 0.000 description 1
239000012634 fragment Substances 0.000 description 1
201000008049 fucosidosis Diseases 0.000 description 1
206010017758 gastric cancer Diseases 0.000 description 1
238000012224 gene deletion Methods 0.000 description 1
238000003197 gene knockdown Methods 0.000 description 1
208000005017 glioblastoma Diseases 0.000 description 1
210000001905 globus pallidus Anatomy 0.000 description 1
YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
208000007345 glycogen storage disease Diseases 0.000 description 1
201000004502 glycogen storage disease II Diseases 0.000 description 1
230000013595 glycosylation Effects 0.000 description 1
238000006206 glycosylation reaction Methods 0.000 description 1
229940093915 gynecological organic acid Drugs 0.000 description 1
201000010536 head and neck cancer Diseases 0.000 description 1
208000014829 head and neck neoplasm Diseases 0.000 description 1
210000005003 heart tissue Anatomy 0.000 description 1
210000001308 heart ventricle Anatomy 0.000 description 1
208000009429 hemophilia B Diseases 0.000 description 1
108010089932 heparan sulfate sulfatase Proteins 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 1
229960001008 heparin sodium Drugs 0.000 description 1
210000003494 hepatocyte Anatomy 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
239000012510 hollow fiber Substances 0.000 description 1
238000002744 homologous recombination Methods 0.000 description 1
230000006801 homologous recombination Effects 0.000 description 1
229960000027 human factor ix Drugs 0.000 description 1
229960002773 hyaluronidase Drugs 0.000 description 1
229920001477 hydrophilic polymer Polymers 0.000 description 1
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
210000003016 hypothalamus Anatomy 0.000 description 1
210000003405 ileum Anatomy 0.000 description 1
239000012216 imaging agent Substances 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
230000005847 immunogenicity Effects 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
238000002991 immunohistochemical analysis Methods 0.000 description 1
238000013388 immunohistochemistry analysis Methods 0.000 description 1
238000010874 in vitro model Methods 0.000 description 1
238000009540 indirect ophthalmoscopy Methods 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
229960003786 inosine Drugs 0.000 description 1
238000002743 insertional mutagenesis Methods 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
210000004347 intestinal mucosa Anatomy 0.000 description 1
230000002601 intratumoral effect Effects 0.000 description 1
238000010253 intravenous injection Methods 0.000 description 1
229960002725 isoflurane Drugs 0.000 description 1
210000001630 jejunum Anatomy 0.000 description 1
229960003299 ketamine Drugs 0.000 description 1
229960004184 ketamine hydrochloride Drugs 0.000 description 1
210000003292 kidney cell Anatomy 0.000 description 1
210000000629 knee joint Anatomy 0.000 description 1
239000008101 lactose Substances 0.000 description 1
210000003140 lateral ventricle Anatomy 0.000 description 1
230000003902 lesion Effects 0.000 description 1
231100000518 lethal Toxicity 0.000 description 1
230000001665 lethal effect Effects 0.000 description 1
208000036546 leukodystrophy Diseases 0.000 description 1
238000001638 lipofection Methods 0.000 description 1
229910052744 lithium Inorganic materials 0.000 description 1
210000005228 liver tissue Anatomy 0.000 description 1
239000012160 loading buffer Substances 0.000 description 1
230000007774 longterm Effects 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
210000001165 lymph node Anatomy 0.000 description 1
108010045758 lysosomal proteins Proteins 0.000 description 1
208000002780 macular degeneration Diseases 0.000 description 1
238000002595 magnetic resonance imaging Methods 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
108020004999 messenger RNA Proteins 0.000 description 1
230000003458 metachromatic effect Effects 0.000 description 1
239000003094 microcapsule Substances 0.000 description 1
230000003278 mimic effect Effects 0.000 description 1
239000002480 mineral oil Substances 0.000 description 1
235000010446 mineral oil Nutrition 0.000 description 1
238000005065 mining Methods 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
150000002772 monosaccharides Chemical class 0.000 description 1
210000002200 mouth mucosa Anatomy 0.000 description 1
206010028093 mucopolysaccharidosis Diseases 0.000 description 1
201000002273 mucopolysaccharidosis II Diseases 0.000 description 1
208000005340 mucopolysaccharidosis III Diseases 0.000 description 1
208000000690 mucopolysaccharidosis VI Diseases 0.000 description 1
208000010978 mucopolysaccharidosis type 4 Diseases 0.000 description 1
201000006417 multiple sclerosis Diseases 0.000 description 1
230000003387 muscular Effects 0.000 description 1
230000000869 mutational effect Effects 0.000 description 1
239000002105 nanoparticle Substances 0.000 description 1
229920005615 natural polymer Polymers 0.000 description 1
239000013642 negative control Substances 0.000 description 1
210000005036 nerve Anatomy 0.000 description 1
210000002569 neuron Anatomy 0.000 description 1
208000033939 neuronal 6A ceroid lipofuscinosis Diseases 0.000 description 1
201000008051 neuronal ceroid lipofuscinosis Diseases 0.000 description 1
201000007642 neuronal ceroid lipofuscinosis 1 Diseases 0.000 description 1
201000007634 neuronal ceroid lipofuscinosis 10 Diseases 0.000 description 1
201000007605 neuronal ceroid lipofuscinosis 11 Diseases 0.000 description 1
201000007659 neuronal ceroid lipofuscinosis 13 Diseases 0.000 description 1
201000007655 neuronal ceroid lipofuscinosis 6 Diseases 0.000 description 1
201000007640 neuronal ceroid lipofuscinosis 7 Diseases 0.000 description 1
201000007638 neuronal ceroid lipofuscinosis 8 Diseases 0.000 description 1
230000007135 neurotoxicity Effects 0.000 description 1
231100000228 neurotoxicity Toxicity 0.000 description 1
108091027963 non-coding RNA Proteins 0.000 description 1
239000002736 nonionic surfactant Substances 0.000 description 1
231100000956 nontoxicity Toxicity 0.000 description 1
238000010899 nucleation Methods 0.000 description 1
239000003921 oil Substances 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
238000002515 oligonucleotide synthesis Methods 0.000 description 1
238000005457 optimization Methods 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
230000007918 pathogenicity Effects 0.000 description 1
230000037361 pathway Effects 0.000 description 1
239000000312 peanut oil Substances 0.000 description 1
102000013415 peroxidase activity proteins Human genes 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
239000003208 petroleum Substances 0.000 description 1
229940124531 pharmaceutical excipient Drugs 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
239000006187 pill Substances 0.000 description 1
239000000902 placebo Substances 0.000 description 1
229940068196 placebo Drugs 0.000 description 1
230000036470 plasma concentration Effects 0.000 description 1
230000008488 polyadenylation Effects 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
239000000843 powder Substances 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
238000012545 processing Methods 0.000 description 1
QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
230000004853 protein function Effects 0.000 description 1
230000001185 psoriatic effect Effects 0.000 description 1
238000000746 purification Methods 0.000 description 1
210000002637 putamen Anatomy 0.000 description 1
230000005855 radiation Effects 0.000 description 1
238000001959 radiotherapy Methods 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
210000005084 renal tissue Anatomy 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
230000002207 retinal effect Effects 0.000 description 1
210000001202 rhombencephalon Anatomy 0.000 description 1
235000009566 rice Nutrition 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
238000004062 sedimentation Methods 0.000 description 1
238000002864 sequence alignment Methods 0.000 description 1
238000011451 sequencing strategy Methods 0.000 description 1
239000008159 sesame oil Substances 0.000 description 1
235000011803 sesame oil Nutrition 0.000 description 1
SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
239000000741 silica gel Substances 0.000 description 1
229910002027 silica gel Inorganic materials 0.000 description 1
235000020183 skimmed milk Nutrition 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
235000010288 sodium nitrite Nutrition 0.000 description 1
RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
239000002904 solvent Substances 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
239000003549 soybean oil Substances 0.000 description 1
235000012424 soybean oil Nutrition 0.000 description 1
241000894007 species Species 0.000 description 1
235000013599 spices Nutrition 0.000 description 1
208000020431 spinal cord injury Diseases 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000008227 sterile water for injection Substances 0.000 description 1
201000011549 stomach cancer Diseases 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
150000005846 sugar alcohols Chemical class 0.000 description 1
239000013595 supernatant sample Substances 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
239000000375 suspending agent Substances 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
229920001059 synthetic polymer Polymers 0.000 description 1
238000012385 systemic delivery Methods 0.000 description 1
239000003826 tablet Substances 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
230000002123 temporal effect Effects 0.000 description 1
210000001103 thalamus Anatomy 0.000 description 1
231100001274 therapeutic index Toxicity 0.000 description 1
210000001685 thyroid gland Anatomy 0.000 description 1
229910052718 tin Inorganic materials 0.000 description 1
231100000440 toxicity profile Toxicity 0.000 description 1
210000003437 trachea Anatomy 0.000 description 1
230000009466 transformation Effects 0.000 description 1
238000013519 translation Methods 0.000 description 1
102000035160 transmembrane proteins Human genes 0.000 description 1
108091005703 transmembrane proteins Proteins 0.000 description 1
230000009529 traumatic brain injury Effects 0.000 description 1
229960004791 tropicamide Drugs 0.000 description 1
230000006107 tyrosine sulfation Effects 0.000 description 1
241000701447 unidentified baculovirus Species 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
210000001186 vagus nerve Anatomy 0.000 description 1
210000003556 vascular endothelial cell Anatomy 0.000 description 1
210000005166 vasculature Anatomy 0.000 description 1
235000013311 vegetables Nutrition 0.000 description 1
210000002845 virion Anatomy 0.000 description 1
238000012800 visualization Methods 0.000 description 1
230000003442 weekly effect Effects 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1